{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260615846661/en/Verastem-Oncology-to-Host-Investor-Conference-Call-and-Report-Updated-Data-and-Progress-Across-VS-7375-Oral-KRAS-G12D-ONOFF-Inhibitor-TARGET-D-Clinical-Program", "message": "News view counter 799986 successfully enlarged"}